MONROVIA, Calif., Aug. 3, 2011 /PRNewswire/ — STAAR Surgical
Company (NASDAQ:
STAA), a leading developer, manufacturer and marketer of
minimally invasive ophthalmic products, today announced that it
will participate in the 2011 Canaccord Genuity Growth Conference at
the Intercontinental Hotel in Boston on Tuesday, August 9, 2011 at
3:30 p.m. Eastern Time.
Barry G. Caldwell, President and CEO, will review the company’s
business strategy and recent corporate developments. STAAR will
offer a live video webcast of its presentation on the Company’s
website, www.staar.com, under Investor
Information. An archived replay of the presentation will be
available for 30 days, also at www.staar.com.
About STAAR SurgicalSTAAR, which has been dedicated
solely to ophthalmic surgery for over 25 years, designs, develops,
manufactures and markets implantable lenses for the eye. All
of these lenses are foldable, which permits the surgeon to insert
them through a small incision. A lens used to replace the
natural lens after cataract surgery is called an intraocular lens
or “IOL.” A lens used in refractive surgery as an alternative
to LASIK is called an Implantable Collamer® Lens or “ICL.”
Over 225,000 Visian ICLs have been implanted to date; to
learn more about the ICL go to: www.visianinfo.com.
STAAR has approximately 300 full time employees and markets
lenses in approximately 50 countries. Headquartered in
Monrovia, CA, it manufactures in the following locations: Nidau,
Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia,
CA. For more information, please visit the Company’s website
at www.staar.com or call
626-303-7902.
Collamer® is the registered tradem
‘/>”/>
